Literature DB >> 1824261

Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma.

S Raghoebier1, M H Kramer, J H van Krieken, D de Jong, J Limpens, J C Kluin-Nelemans, G J van Ommen, P M Kluin.   

Abstract

Large cell lymphomas (LCLs) are heterogeneous in morphology, clinical presentation, and behavior. We studied 52 de novo LCLs of B-cell type for rearrangements of the bcl-2 and c-myc oncogenes by Southern blot analysis and related these data to the primary site of presentation, stage, and cytomorphology. Thirteen tumors had comigrating rearrangements of JH and bcl-2, indicative of a t(14;18). Far more primary nodal lymphomas than extranodal lymphomas carried a t(14;18) (40% v less than 5%). Additionally, almost all lymphomas with a t(14;18) versus 41% of the tumors without a bcl-2 rearrangement presented with lymphadenopathy. c-myc rearrangements were seen in 35% of the extranodal lymphomas and 5% of the nodal lymphomas. No differences were observed in bone marrow involvement and staging according to Ann Arbor. bcl-2 rearrangements were found in 50% of the LCLs with cleaved nuclei, whereas c-myc rearrangements were relatively frequent (25%) in the noncleaved subtype. Our data support the hypothesis that primary nodal and extranodal lymphomas have a different genetic origin.

Entities:  

Mesh:

Year:  1991        PMID: 1824261

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis.

Authors:  Song-Yi Choi; Seok Jin Kim; Won Seog Kim; Kihyun Kim; Young-Hyeh Ko
Journal:  Virchows Arch       Date:  2011-10-15       Impact factor: 4.064

2.  De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.

Authors:  A Matolcsy; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

3.  Expression of the bcl-2 protein in B cell lymphomas arising from mucosa associated lymphoid tissue.

Authors:  E Navratil; P Gaulard; P Kanavaros; J Audouin; J Bougaran; N Martin; J Diebold; D Y Mason
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

4.  p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time.

Authors:  M A Piris; F Pezzella; J C Martinez-Montero; J L Orradre; R Villuendas; M Sanchez-Beato; R Cuena; M A Cruz; B Martinez; F ] Pezella F [corrected to Pezzella
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.